🔎 Trials Near Me

Почетна › Неуробластом › Kalifornija

Kliničke studije za Неуробластом u državi Kalifornija

15 studija za Неуробластом traži učesnike na lokacijama u državi Kalifornija.

Gradovi u državi Kalifornija

Zvanični tekst studije (na engleskom)

Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

  • UCSF Benioff Children's Hospital Oakland, Oakland
  • UC Davis Comprehensive Cancer Center, Sacramento
  • Rady Children's Hospital, San Diego
Тражи се учесникФаза 1/2
До 30 година · Оба пола · Ажурирано 12. 11. 2026. · NCT06541262

Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse

  • Children's Oncology Group, Oakland
Тражи се учесникФаза 1/2
Узраст од 1 до 30 · Оба пола · Ажурирано 6. 11. 2026. · NCT07437963

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

  • Kaiser Permanente Downey Medical Center, Downey
  • City of Hope Comprehensive Cancer Center, Duarte
  • Loma Linda University Medical Center, Loma Linda
  • и још 13
Тражи се учесникФаза 3
До 30 година · Оба пола · Ажурирано 30. 10. 2026. · NCT06172296

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

  • Children's Hospital Los Angeles ( Site 1006), Los Angeles
Тражи се учесникФаза 1/2
6 Months – 25 Years · Оба пола · Ажурирано 30. 10. 2026. · NCT06395103

PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors

  • Cedars-Sinai Medical Center, Los Angeles
  • University of California, San Francisco, San Francisco
Тражи се учесникФаза 1/2
Узраст од 1 до 30 · Оба пола · Ажурирано 6. 10. 2026. · NCT06721689

MCT for the Harvard/UCSF ROBIN Center

  • University of California, San Francisco, San Francisco
Тражи се учесник
Сви узрасти · Оба пола · Ажурирано 1. 10. 2026. · NCT06000787

Pediatric Precision Laboratory Advanced Neuroblastoma Therapy

  • UCSF Benioff Children's Hospital Oakland, Oakland
  • Rady Children's Hospital, San Diego
Тражи се учесникФаза 2
До 22 година · Оба пола · Ажурирано 4. 9. 2026. · NCT02559778

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

  • Kaiser Permanente Downey Medical Center, Downey
  • Loma Linda University Medical Center, Loma Linda
  • Children's Hospital Los Angeles, Los Angeles
  • и још 9
Тражи се учесникФаза 3
365 Days – 30 Years · Оба пола · Ажурирано 25. 8. 2026. · NCT03126916

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • Children's Hospital Los Angeles, Los Angeles
  • Children's Hospital of Orange County, Orange
  • UCSF Medical Center-Mission Bay, San Francisco
Тражи се учесникФаза 1/2
12 Months – 30 Years · Оба пола · Ажурирано 25. 8. 2026. · NCT04851119

Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma

  • UCSF Benioff Children's Hospital Oakland, Oakland
  • Rady Children's Hospital, San Diego
Тражи се учесникФаза 2
12 Months – 21 Years · Оба пола · Ажурирано 12. 8. 2026. · NCT05489887

SPEARHEAD-3 Pediatric Study

  • Stanford University, Palo Alto
Тражи се учесникФаза 1/2
Узраст од 2 до 21 · Оба пола · Ажурирано 11. 8. 2026. · NCT05642455

NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial

  • Children's Hospital Los Angeles, Los Angeles
  • UCSF Benioff Children's Hospital, San Francisco
Тражи се учесникФаза 2
Узраст од 1 до 31 · Оба пола · Ажурирано 20. 7. 2026. · NCT06450041

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

  • Lucille Packard Children's Hospital Stanford, Palo Alto
Тражи се учесникФаза 1/2
12 Months – 30 Years · Оба пола · Ажурирано 19. 5. 2026. · NCT04901702

Autologous B7-H3 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Solid Tumors

  • Stanford University, Palo Alto
Тражи се учесникФаза 1
Узраст од 2 до 30 · Оба пола · Ажурирано 7. 5. 2026. · NCT06500819

Neuroblastoma Biology Study

  • Children's Hospital Los Angeles, Los Angeles
  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Тражи се учесникОпсервациона студија
31 Days – 99 Years · Оба пола · Ажурирано 23. 3. 2026. · NCT01587300

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.